NGM

NGM Biopharmaceuticals, Inc. Common Stock
NGM

Overview Fund Activity
Delisted

NGM was delisted on the 4th of April, 2024.

Back to rankings

120 hedge funds and large institutions have $951M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 44 increasing their positions, 25 reducing their positions, and 12 closing their positions.

Holders
120
Holders Change
+13
Holders Change %
+12.15%
% of All Funds
2.11%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.11%
New
25
Increased
44
Reduced
25
Closed
12
Calls
$8M
Puts
$2.63M
Net Calls
+$5.36M
Net Calls Change
+$4.74M

Top Buyers

1
SG
1
StepStone Group
California
$33.1M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$27.5M
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$30.3M
4
Jacobs Levy Equity Management
4
Jacobs Levy Equity Management
New Jersey
$9.63M
5
Two Sigma Investments
5
Two Sigma Investments
New York
$4.38M

Top Sellers

1
ACM
1
Aquilo Capital Management
California
$0
2
EC
2
Euclidean Capital
New York
$17.5M
3
RG
3
Redmile Group
California
$52.7M
4
EC
4
EcoR1 Capital
California
$0
5
HF
5
HRT Financial
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
CG
1
Column Group
California
$324M 15,396,116 – –
RCP
2
Rho Capital Partners
New York
$79.2M 3,766,666 – –
RG
3
Redmile Group
California
$52.7M 2,505,118 -287,330 -10%
BlackRock
4
BlackRock
New York
$51.4M 2,444,832 +145,477 +6%
SG
5
StepStone Group
California
$33.1M 1,573,357 +1,573,357 New
Vanguard Group
6
Vanguard Group
Pennsylvania
$32.8M 1,560,125 +171,051 +12%
Point72 Asset Management
7
Point72 Asset Management
Connecticut
$30.3M 1,442,994 +578,794 +67%
Fidelity Investments
8
Fidelity Investments
Massachusetts
$27.5M 1,307,937 +1,307,937 New
PIM
9
Ponoi II Management
California
$27.3M 1,298,908 – –
PM
10
Ponoi Management
California
$27.3M 1,298,908 – –
BI
11
BVF Inc
California
$20.1M 955,000 – –
EC
12
Euclidean Capital
New York
$17.5M 832,274 -661,075 -44%
Citadel Advisors
13
Citadel Advisors
Florida
$15.9M 758,655 +50,576 +7%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$13.5M 643,873 +68,077 +12%
JPMorgan Chase & Co
15
JPMorgan Chase & Co
New York
$13.2M 627,118 +14,245 +2%
State Street
16
State Street
Massachusetts
$13.1M 621,163 +26,545 +4%
CS
17
Candriam SCA
Luxembourg
$11.9M 564,059 – –
BC
18
Boxer Capital
California
$10.5M 500,000 – –
Jacobs Levy Equity Management
19
Jacobs Levy Equity Management
New Jersey
$9.63M 457,946 +205,123 +81%
Axa
20
Axa
France
$8.52M 405,367 +112,926 +39%
T. Rowe Price Associates
21
T. Rowe Price Associates
Maryland
$8.09M 384,716 -49,142 -11%
JRP
22
Jasper Ridge Partners
California
$6.52M 310,250 – –
Northern Trust
23
Northern Trust
Illinois
$6.3M 299,460 +2,020 +0.7%
BBA
24
Baker Bros. Advisors
New York
$6.13M 291,801 – –
HWAM
25
Hennion & Walsh Asset Management
New Jersey
$5.82M 276,990 -9,468 -3%
1
2 3 4 5